Fengshu Zhao

1.0k total citations
49 papers, 872 citations indexed

About

Fengshu Zhao is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fengshu Zhao has authored 49 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 27 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Fengshu Zhao's work include Immunotherapy and Immune Responses (27 papers), Cancer Cells and Metastasis (17 papers) and Cancer Research and Treatments (8 papers). Fengshu Zhao is often cited by papers focused on Immunotherapy and Immune Responses (27 papers), Cancer Cells and Metastasis (17 papers) and Cancer Research and Treatments (8 papers). Fengshu Zhao collaborates with scholars based in China, United States and Australia. Fengshu Zhao's co-authors include Jun Dou, Weihua Hu, Lili Chu, Ning Gu, Kai Hu, Meng Pan, Yating Li, Di Wu, Xiangfeng He and Meng Pan and has published in prestigious journals such as Geological Society of America Bulletin, Biochemical Pharmacology and European Journal of Neuroscience.

In The Last Decade

Fengshu Zhao

45 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengshu Zhao China 19 456 412 365 196 83 49 872
Munehide Nakatsugawa Japan 21 783 1.7× 672 1.6× 683 1.9× 193 1.0× 62 0.7× 79 1.4k
Łukasz Magiera United Kingdom 7 922 2.0× 455 1.1× 610 1.7× 251 1.3× 72 0.9× 10 1.4k
Iva Truxová Czechia 16 648 1.4× 299 0.7× 729 2.0× 94 0.5× 42 0.5× 24 1.2k
Mark C. Glassy United States 19 260 0.6× 609 1.5× 494 1.4× 121 0.6× 77 0.9× 74 1.1k
Sima J. Zacharek United States 13 320 0.7× 821 2.0× 387 1.1× 123 0.6× 37 0.4× 16 1.2k
Akira Yuno United States 16 411 0.9× 459 1.1× 383 1.0× 66 0.3× 34 0.4× 29 844
Zhenqing Feng China 14 368 0.8× 261 0.6× 204 0.6× 150 0.8× 33 0.4× 26 674
John G. Facciponte United States 17 236 0.5× 407 1.0× 393 1.1× 81 0.4× 44 0.5× 17 718
Monica Banica United States 4 363 0.8× 283 0.7× 768 2.1× 277 1.4× 54 0.7× 6 1.2k
Melissa Wassink Netherlands 13 184 0.4× 453 1.1× 435 1.2× 75 0.4× 70 0.8× 16 828

Countries citing papers authored by Fengshu Zhao

Since Specialization
Citations

This map shows the geographic impact of Fengshu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengshu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengshu Zhao more than expected).

Fields of papers citing papers by Fengshu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengshu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengshu Zhao. The network helps show where Fengshu Zhao may publish in the future.

Co-authorship network of co-authors of Fengshu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengshu Zhao. A scholar is included among the top collaborators of Fengshu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengshu Zhao. Fengshu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Peng, et al.. (2025). The progress and prospect of in-situ observation and microanalysis techniques applied in the ore deposit research. Bulletin of Mineralogy Petrology and Geochemistry. 44(5). 947–958.
2.
Dong, Wen, Fengshu Zhao, Tianqi Liu, et al.. (2025). Prediction of metachronous liver metastasis in mid-low rectal cancer using quantitative perirectal fat content from high-resolution MRI. Magnetic Resonance Imaging. 118. 110338–110338.
3.
Xu, Hui, Fengshu Zhao, Di Wu, et al.. (2023). Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination. Biomedicine & Pharmacotherapy. 161. 114547–114547. 8 indexed citations
4.
Shi, Fangfang, Rui Xue, Hui Xu, et al.. (2022). Mucin 1 downregulation decreases the anti-tumor effects of melanoma vaccine. Annals of Translational Medicine. 10(24). 1361–1361. 1 indexed citations
5.
Dou, Jun, Luoyang Li, Mei Guo, et al.. (2021). Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species. International Journal of Nanomedicine. Volume 16. 1231–1244. 14 indexed citations
6.
Zhao, Fengshu, et al.. (2021). Amsp3 may act upstream of Amdnmt3 in female caste differentiation in the honeybee ( Apis mellifera ). Insect Molecular Biology. 30(5). 532–540.
7.
Li, Miao, Meng Pan, Jing Wang, et al.. (2020). miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression. Molecular Therapy — Oncolytics. 18. 70–82. 28 indexed citations
8.
Pan, Meng, et al.. (2020). Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer. International Immunopharmacology. 88. 106850–106850. 18 indexed citations
9.
Pan, Meng, et al.. (2020). MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine. International Immunopharmacology. 85. 106631–106631. 30 indexed citations
10.
Wang, Xiaoying, et al.. (2020). <p>Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition</p>. Cancer Management and Research. Volume 12. 663–673. 7 indexed citations
12.
Dou, Jun, Xiangfeng He, Yurong Liu, et al.. (2013). Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs. Cell Biology International. 38(4). 452–461. 28 indexed citations
13.
Wang, Jing, Fengshu Zhao, Dengyu Chen, et al.. (2012). Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse. Immunologic Research. 52(3). 240–249. 24 indexed citations
14.
Hu, Kai, Xiangfeng He, Xianwen Yuan, et al.. (2011). Immunization with DNA Vaccine Expressing Herpes Simplex Virus Type 1 gD and IL-21 Protects against Mouse Herpes Keratitis. Immunological Investigations. 40(3). 265–278. 15 indexed citations
15.
Zhao, Fengshu, Jun Dou, Xiang He, et al.. (2010). Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Vaccine. 28(16). 2846–2852. 34 indexed citations
16.
Wang, Jia, et al.. (2010). Immunotherapy of melanoma by GPI-anchored IL-21 tumour vaccine involves down-regulating regulatory T cells in mouse model. International Journal of Immunogenetics. 38(1). 21–29. 3 indexed citations
17.
Dou, Jun, Quan Tang, Haitao Yang, et al.. (2009). Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model. Immunobiology. 215(2). 133–142. 23 indexed citations
18.
Zhao, Fengshu, Jun Dou, Jing Wang, et al.. (2009). Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice. Immunobiology. 215(2). 89–100. 17 indexed citations
19.
Dou, Jun, Quan Tang, Fengshu Zhao, et al.. (2008). Comparison of Immune Responses Induced in Mice by Vaccination with DNA Vaccine Constructs Expressing Mycobacterial Antigen 85A and Interleukin-21 and Bacillus Galmette-Guérin. Immunological Investigations. 37(2). 113–127. 22 indexed citations
20.
Dou, Jun, et al.. (2006). Investigation of GM-CSF Immune Accessory Effects in Tumor-Bearing Mice by Direct Gene Immunization. Immunological Investigations. 35(2). 227–237. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026